Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade

Duygu Kocyigit, Kadri Murat Gurses, Muhammed Ulvi Yalcin, Lale Tokgozoglu
  • Endocrine Metabolic & Immune Disorders - Drug Targets, June 2017, Bentham Science Publishers
  • DOI: 10.2174/1871530317666170424101846

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.2174/1871530317666170424101846

The following have contributed to this page: Kadri Murat Gurses

In partnership with: